You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

CLINICAL TRIALS PROFILE FOR METHYLPHENIDATE

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for METHYLPHENIDATE

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00000268 ↗	Cocaine Abuse and Attention Deficit Disorder - 3	Completed	New York State Psychiatric Institute	N/A	1995-05-01	The purpose of this study is to evaluate cocaine abuse and Attention Deficit Disorder
NCT00000268 ↗	Cocaine Abuse and Attention Deficit Disorder - 3	Completed	National Institute on Drug Abuse (NIDA)	N/A	1995-05-01	The purpose of this study is to evaluate cocaine abuse and Attention Deficit Disorder
NCT00003266 ↗	Methylphenidate in Treating Patients With Melanoma	Completed	National Cancer Institute (NCI)	Phase 3	1999-06-01	RATIONALE: Methylphenidate may relieve some of the side effects of chemotherapy in patients with melanoma. It is not known whether receiving methylphenidate is more effective than receiving no further therapy in treating patients with melanoma. PURPOSE: Randomized phase III trial to determine if methylphenidate is more effective than no further therapy for the relief of fatigue and drowsiness in treating patients with melanoma who have received high-dose interferon alfa for 8-24 weeks.
NCT00003266 ↗	Methylphenidate in Treating Patients With Melanoma	Completed	Eastern Cooperative Oncology Group	Phase 3	1999-06-01	RATIONALE: Methylphenidate may relieve some of the side effects of chemotherapy in patients with melanoma. It is not known whether receiving methylphenidate is more effective than receiving no further therapy in treating patients with melanoma. PURPOSE: Randomized phase III trial to determine if methylphenidate is more effective than no further therapy for the relief of fatigue and drowsiness in treating patients with melanoma who have received high-dose interferon alfa for 8-24 weeks.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for METHYLPHENIDATE

Condition Name

Chart
Table

Condition Name for METHYLPHENIDATE
Intervention	Trials
Attention Deficit Hyperactivity Disorder	100
ADHD	47
Attention Deficit Disorder With Hyperactivity	46
Healthy	19
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for METHYLPHENIDATE
Intervention	Trials
Attention Deficit Disorder with Hyperactivity	216
Hyperkinesis	147
Disease	87
Fatigue	26
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for METHYLPHENIDATE

Trials by Country

Map
Table

Trials by Country for METHYLPHENIDATE
Location	Trials
United States	630
Canada	42
Israel	26
Germany	21
France	17
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for METHYLPHENIDATE
Location	Trials
California	46
New York	41
Texas	41
Massachusetts	41
Ohio	39
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for METHYLPHENIDATE

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for METHYLPHENIDATE
Clinical Trial Phase	Trials
Phase 4	138
Phase 3	81
Phase 2/Phase 3	15
[disabled in preview]	57
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for METHYLPHENIDATE
Clinical Trial Phase	Trials
Completed	261
Unknown status	45
Recruiting	36
[disabled in preview]	25
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for METHYLPHENIDATE

Sponsor Name

Chart
Table

Sponsor Name for METHYLPHENIDATE
Sponsor	Trials
National Institute of Mental Health (NIMH)	29
Massachusetts General Hospital	28
National Institute on Drug Abuse (NIDA)	19
[disabled in preview]	14
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for METHYLPHENIDATE
Sponsor	Trials
Other	447
Industry	136
NIH	80
[disabled in preview]	21
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.